-
Taxonomy & unit
-
us-gaap: CAD and USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Arbutus Biopharma Corp quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
- Arbutus Biopharma Corp Operating Income (Loss) for the quarter ending June 30, 2024 was -$21.6M, a 17.4% decline year-over-year.
- Arbutus Biopharma Corp Operating Income (Loss) for the twelve months ending June 30, 2024 was -$83.3M, a 9.3% decline year-over-year.
- Arbutus Biopharma Corp annual Operating Income (Loss) for 2023 was -$78.1M, a 19.3% decline from 2022.
- Arbutus Biopharma Corp annual Operating Income (Loss) for 2022 was -$65.5M, a 11% increase from 2021.
- Arbutus Biopharma Corp annual Operating Income (Loss) for 2021 was -$73.5M, a 27.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)